病原体の進化に対応するために不可欠な更新されたファージバンク:Klebsiella pneumoniaeとそのファージからの教訓
Pallavi Bhat Ajakkala1, Apoorva R Kenjar1, Sujana Prabell1
1Department of Infectious Diseases and Microbial Genomics, Nitte University Centre for Science Education and Research, Nitte (Deemed to be University), Mangaluru, 575018, Karnataka, India.
まとめ
バイオフィルムを含む多剤耐性Klebsiella肺炎 (MDR-KP) 感染症に対して,リチ菌菌は有望である. しかしバクテリアの進化は 効果的な治療のためにファージバンクの継続的な更新を必要とします
科学分野:
- 微生物学
- 感染症
- バイオテクノロジー
背景:
- 多剤耐性Klebsiella pneumoniae (MDR-KP) は,バイオフィルム形成などの毒性の要因により,世界的な健康上の重大な脅威となっている.
- 抗生物質耐性は 代替策を必要とし 細菌菌治療への新たな関心が生まれています
- 細菌の病原体は動的に進化し,細菌菌に対する耐性を生み出す可能性があります.
研究 の 目的:
- MDR-KPに対するリチ性活性を持つ細菌菌を分離し,特徴づけること.
- 候補ファグの抗菌膜の有効性を評価する.
- MDR-KPにおけるファグ耐性の進化を時間とともに評価する.
主な方法:
- 280のMDR-KP臨床単離物に対する細菌菌の分離とスクリーニング
- 宿主範囲とDNA指紋によるファグのグループ化
- 選択された候補ファグの全ゲノム配列決定
主要な成果:
- 5つの候補ファージは,広範囲の宿主,強い細菌分解性,および有意な抗菌フィルム活性を示した.
- ファージKPØ6は,広範囲の宿主を含む新型タイペウイルスとして特定されました.
- 2018~2020年と2022~23年の間にMDR-KPファグ耐性の顕著な増加が観察されました.
結論:
- 炎症性細菌菌は,MDR-KP感染の管理に有効な代替手段であり,特に医療環境において有効である.
- 特徴づけられたファージは,バイオフィルム関連感染症を含むMDR-KPに対する生物制御および治療用途の可能性を示しています.
- バクテリアの耐性の急速な進化は,ファグの収集を定期的に更新することの重要性を強調しています.
関連する概念動画
01:30Lytic Cycle of Bacteriophages
71.9K
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
71.9K
00:43Lysogenic Cycle of Bacteriophages
63.1K
In contrast to the lytic cycle, phages infecting bacteria via the lysogenic cycle do not immediately kill their host cell. Instead, they combine their genome with the host genome, allowing the bacteria to replicate the phage DNA along with the bacterial genome. The incorporated copy of the phage genome is called the prophage. Some prophages can re-activate and enter the lytic cycle. This often occurs in response to a perturbation, such as DNA damage, but can also transpire in the absence of...
63.1K
01:16Viral Replication: Lysogenic Cycle
208
The lysogenic cycle is a crucial viral replication strategy that allows bacteriophages to persist within host cells without immediately destroying them. This process is primarily observed in temperate phages, such as bacteriophage lambda (λ), which infects Escherichia coli. The cycle allows the viral genome to persist across bacterial generations while keeping host cells viable.Integration of the Viral GenomeUpon infection, bacteriophage lambda attaches to the bacterial surface and injects...
208
01:26DNA Bacteriophages
140
Bacteriophages, or phages, are viruses that specifically infect bacteria, utilizing their genetic material to hijack host cellular machinery for replication. DNA bacteriophages employ single-stranded DNA (ssDNA) or double-stranded DNA (dsDNA) genomes. These phages exhibit diverse replication strategies and host interactions, influencing their ecological roles and applications in biotechnology and medicine.ssDNA BacteriophagesssDNA phages, with their small genomes, utilize unique strategies to...
140
01:20Viral Replication: Lytic Cycle
217
Bacteriophages, or phages, are viruses that specifically infect bacteria. Among them, T-even bacteriophages, such as T4, exhibit a well-characterized lytic replication cycle in Escherichia coli (E. coli). This process ensures the rapid proliferation of the virus while ultimately leading to the destruction of the bacterial host.Attachment and DNA InjectionThe infection process begins with the recognition and binding of the T4 phage to the E. coli cell surface. Tail fibers of the phage...
217
00:36Viral Mutations
32.8K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
32.8K